| Open Trial |
Description |
| NCIC CTG EN.4 |
Randomized trial of Radiotherapy vs. Observation in Stage 1 and 2 Uterine Sarcomas
Contact: Dr. Robert Grimshaw |
| NCIC CTG EN.5 |
A phase III randomized trial comparing TAH BSO versus TAH BSO plus adjuvant pelvic irradiation in Stage I (intermediate risk) carcinoma of the endometrium
Contact: Dr. Robert Grimshaw |
| NESP-980291 |
A randomized, double blind, placebo controlled, dose finding study of novel erythropoiesis stimulating protein (NESP) administered once every three weeks by subcutaneous (SC) injection for the treatment of anemia in patients with solid tumours receiving multicycle chemotherapy
Contact: Dr. Robert Grimshaw |
| NCIC-CTG OV.13 |
An international multi-centre, randomized phase III study comparing upfront debulking surgery vs. Neo-adjuvant chemotherapy in patients with Stage IIIC or IV epithelial ovarian cancer
Contact: Dr. Robert Grimshaw |
| NCIC-CTG OV.14 |
International, randomized, phase III trial of Paclitaxel/Epirubicin/Carboplatin (TEC) vs. Paclitaxel/Carboplatin (TC)in the initial treatment of women with advanced epithelial ovarian cancer
Contact: Dr. Robert Grimshaw |
| NCIC CTG IND.138 |
A Randomized phase II study of NX 211 given by two different intravenous schedules in advanced and/or recurrent epithelial ovarian cancer
Contact: Dr. Robert Grimshaw |
| NCIC CTG OV.15 |
A Randomized Phase III Study comparing Gemcitabine Plus Carboplatin vs Carboplatin in patients with recurrent Ovarian cancer
Contact: Dr. Robert Grimshaw |
